To support the EFMC efforts to showcase the continuum between Medicinal Chemistry and Chemical Biology, we need your contribution to share the best picture representing what is your vision of "Bridging MedChem and ChemBio".
Do you feel up to the challenge!?
We want scientists from any level and affiliation to take the best shot possible and enter the competition! The submitted pictures will be judged by a first round of online voting and the 20 best shots will be showcased at the EFMC-ISMC 2021 for attendees to vote live!
Submit your best picture, and win up to €200 in the EFMC’s photo competition!
Deadline to submit your picture is August 10, 2021
Over the last two years, EFMC has developed a long-term vision for its role in medicinal chemistry and chemical biology, and has implemented a strong strategy to reinforce the support of the community it represents. This has led to changes in the scope of EFMC activities, now better uniting the chemical biology and medicinal chemistry community, and following the evolution of this scientific discipline.
It felt only natural for our monthly newsletter to become the column for both chemical biology and medicinal chemistry, aiming to share with you the relevant information about upcoming activities organised by the EFMC or its partners, for the benefit of the extended scientific community.
The EFMC is happy to announce the names of the 2021 Prize winners.
The selection committee designated Prof. Nir London (Weizmann Institute of Science, Israel) as the winner of the 2021 EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Academia.
Prof. Finn Hansen (University of Bonn, Germany) and Prof. Markus Muttenthaler (University of Vienna, Austria) have been recognised as the most meritorious runners-up.
The selection committee designated Dr Niall Anderson (GlaxoSmithKline, United Kingdom) as the winner of the 2021 EFMC Prize for a Young Medicinal Chemist or Chemical Biologist in Industry.
Dr Stephanie Gueret (AstraZeneca, Sweden) and Dr Christian Kramer (F. Hoffmann-La Roche, Switzerland) have been recognised as the most meritorious runners-up.
The two Prizes are given annually and consists of a diploma, € 1.000 and an invitation for a short presentation at an EFMC symposium. The 2021 prize-winners will be invited to give oral communications at the XXVI EFMC "International Symposium on Medicinal Chemistry" (EFMC-ISMC 2021).
The EFMC is very proud to announce the 2021 EFMC Honorary Fellows.
EFMC Honorary Fellow is a life-long title aiming to recognize the individuals who have provided outstanding support to the EFMC and contributed in strengthening the position of medicinal chemistry, chemical biology or related fields in Europe.
Congratulations and thanks to:
- Prof. Bernd Clement is worldwide recognized for his seminal and innovative contributions to medicinal chemistry, namely in fields of drug metabolism and prodrug chemistry. In addition to the impact on drug discovery and drug development, the committee also considered particularly relevant his contributions in strengthening the position of medicinal chemistry at European level. Prof. Clement has been always one of the most active members of EFMC, being a Council member since 2007 representing the Pharmaceutical/Medicinal Chemistry group of the German Pharmaceutical Society. He was the co-chair of the 22nd EFMC International Symposium on Medicinal Chemistry in Berlin (2012), which was a great success. Prof. Clement also played a major role in medicinal chemistry within other major international societies.
Ly and Edmond Differding were proposed for a joint nomination to the EFMC Honorary Fellowship. While this recognition is normally meant for single individuals, the committee felt that the contribution of Ly and Edmond Differding to EFMC, and to the advancement of medicinal chemistry in Europe, can hardly be separated. Edmond Differding was EFMC secretary and vice-chair, contributing to the reorganization of the EFMC, and to the development of its new structure at a period that critically shaped the Federation. More recently, he was actively involved in the celebration of EFMC’s 50th anniversary, preparing two papers that review the scientific content of all EFMC-ISMC and the development of medicinal chemistry in Europe. Ly Differding plays a pivotal role in EFMC and in the organisation of the most important EFMC conferences. She actively participates in EFMC activities and not only guarantees operational support, but also provides constant advice and an historical perspective to the president, executive committee, and conference organizers. Her dedicated contributions to the success of EFMC and medicinal chemistry in Europe is unparalleled. Furthermore, Ly fully supported EFMC during the recent pandemic crisis, proactively looking for creative solutions and facilitating their implementation.
In addition, the committee decided to consider for posthumous recognition:
- Prof. Wijbe Nauta (d. 1986) was one of the founding fathers of the EFMC. He was Secretary in the early years of EFMC, playing a key role in the internationalization of the first national organizations and promoting medicinal chemistry as an independent chemical discipline, especially characterised by its interdisciplinary nature. As member of the UPAC’s commission on medicinal chemistry, part of the Division of Organic Chemistry, Prof. Nauta promoted EFMC through his contributions to the IUPAC Medicinal Chemistry Newsletter. Importantly, he took the initiative to organize the fourth ISMC in1974. He also initiated the book series Pharmacochemistry Library (Elsevier), of which more than 35 volumes were published, being the first editor of this series. The EFMC Pharmacochemistry Award for medicinal chemistry and chemical biology carries his name. Prof. Nauta kept a large amount of documentation regarding the first years of the Federation, which are now in the archives of EFMC.
Dr Emilio Kyburz (d. 2005) was very active in EFMC, as he was member of the executive committee in 1989, vice-chair in 1991-92, elected as chairman in 1995, secretary in 1997 and re-elected in this position in 1999. During this period, Dr. Kyburz put much emphasis on internationalisation of the medicinal chemistry developed in Europe, especially the expanding the interactions with the ACS. His well-curated archives, combined with those of Prof. Nauta, allowed EFMC to revisit its history for the first 30 years of existence.
The official ceremony will take place during the opening of the XXVI EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2021), scheduled to take place from August 29-September 2, 2021.
The EFMC Recognition Programme will continue awarding outstanding contributors to EFMC and sciences in the future. More information will be available here: www.efmc.info/honorary-fellows.
To celebrate its golden jubilee, the EFMC has commissioned a series of articles charting its history, activities and future directions. We are most grateful to ChemMedChem for its support and publishing these articles.
With the contribution of Henk Timmerman in collecting his "Memoirs of the First 50 Years of the European Federation for Medicinal Chemistry" and the extraordinary archivist efforts of Edmond Differding to gather and write both:
- "50 Years European Federation for Medicinal Chemistry (EFMC) – The Ascent of Medicinal Chemistry in Europe"
- "Trends in Drug Discovery over Five Decades – The European Federation for Medicinal Chemistry International Symposium on Medicinal Chemistry (EFMC−ISMC)"
The EFMC is now able to look with pride over its history.
To launch 2021 under good auspices, the EFMC is happy to unveil its new logo and visual identity. After 50 years of existence, EFMC rejuvenates its image, as it takes a leap into the digital era and opens a new chapter of its history.
Those who know our Federation will still recognise themselves in this more dynamic and sleeker version of our beloved logo. The major change lays in the words:
European Federation for Medicinal Chemistry and Chemical Biology
EFMC strongly believes that both disciplines are part of a scientific continuum, ranging from the development of chemical tools to interrogate cellular biology, to the discovery of innovative drug candidates and clinical imaging agents. It is only natural that EFMC’s name acknowledges that it fully represents this extended community.
A Job/PhD or Post-Doc position to offer in medicinal chemistry or chemical biology? Use the EFMC Job Portal
The posting of Job/PhD & Post-Doc offers is free and is available for any Med Chem related jobs, in industry as well as academic positions.
Job posting is now made even simplier, you only have to provide the URL of the job application.
Once reviewed, the position will be available on the EFMC website and in the monthly newsletter "MedChemWatch".